US AIDS Group Hails Brazil for Breaking Merck’s AIDS Drug Patent

Brazzil Magazine covers

Brazil produces some of its own AIDS drugs AIDS Healthcare Foundation (AHF), the US' largest provider of HIV/AIDS healthcare, education and prevention hailed the news that the President of Brazil, Luiz Inácio Lula da Silva, signed today a compulsory license for Merck's HIV/AIDS drug Efavirenz, freeing the country to buy a generic formula of the medication or produce it in its all state laboratories.

AHF also operates free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia. For them, Lula's move is seen as a victory for global AIDS activism and AIDS patients worldwide.

President Lula de Silva's decision comes after reports of a breakdown in negotiations between Brazil and the New Jersey based drug giant Merck. According to the country's health ministry, Brazil had asked Merck to cut the price of Efavirenz to 65 cents a pill from $1.57 and Merck had refused.

Brazil's decision to issue a compulsory license for the drug, which will allow the country to manufacture the drug or to buy generic versions, comes on the heels of Thailand's recent move to issue a compulsory license for Abbott's AIDS drug, Kaletra and in the lead-up to an AIDS Healthcare Foundation-hosted discussion regarding AIDS drug-pricing for Mexico, scheduled for June 4th in Mexico City.

"In announcing its intention to issue a compulsory license for Merck's AIDS drug Efavirenz, Brazil is once again leading the way to affordable AIDS drug access for every nation," added Michael Weinstein, President of AIDS Healthcare Foundation.

"We salute the courage of countries such as Brazil, Thailand and Mexico who are fighting to ensure drug access for AIDS patients the world over. Today is a victory for AIDS activists and patients everywhere, and proof that drug companies will go down in defeat every time they place themselves in the way of justice for AIDS patients."

Flexibilities under the World Trade Organization's (WTO) Trade-related Aspects of Intellectual Property Rights (TRIPS) Agreement allow governments to issue compulsory licenses (including royalty payment to the patent owner) if the country deems it necessary and appropriate to protect the health of its citizens.

Brazil has been widely praised by global AIDS treatment activists for its government AIDS program, which provides free medication for anyone who needs it.

In the Latin American region, AIDS Healthcare Foundation operates free HIV/AIDS treatment clinics in Guatemala (Quetzaltenango) and in Mexico (Tijuana and Puerto Vallarta).

Tags:

You May Also Like

Brazzil Magazine covers

Presidential Offense

"People who retire before they are 50 are lazy bums who enrich from a ...

Brazzil Magazine covers

How Brazil’s Cardoso Left Marxism, But Not Marx Way of Seeing History

To the many critics in both the ivory tower and the political realm who ...

Brazzil Magazine covers

Caretaker Who Toppled Brazil’s Finance Minister Sues Federal Savings Bank

Francenildo dos Santos Costa, the caretaker whose March 14th testimony contradicting earlier public testimony ...

Brazzil Magazine covers

More Popular Than Ever, Brazil’s Lula Grants God Brazilian Citizenship

On the campaign trail for the coming municipal elections in Brazil next October, Brazilian ...

Brazzil Magazine covers

Deceitful and Inconsistent, Brazil Is No Third World Champion

The latest round of WTO negotiations has been nothing if not dramatic, and in ...

Brazzil Magazine covers

Brazil’s New Stimulus Package Is Old Prescription that Won’t Work, Says Economist

José Márcio Camargo, a professor of economics at the Catholic University of Rio de ...